Back to top

Image: Bigstock featured highlights include Clovis Oncology, NiSource, DocuSign, Root and Endava

Read MoreHide Full Article

For Immediate Release

Chicago, IL – December 22, 2022 – Stocks in this week’s article are Clovis Oncology , NiSource (NI - Free Report) , DocuSign (DOCU - Free Report) , Root (ROOT - Free Report) and Endava (DAVA - Free Report) .

Bet on 5 Top Stocks with Rising P/E Ratios

Investors always look for stocks with low P/E ratios as the measure indicates undervaluation. This ratio is obtained by dividing a stock's current market price by its historical or estimated earnings. It tells how much an investor needs to shell out per dollar of earnings.

In fact, the golden rule is – the lower the P/E of a stock, the higher its value will be for investors. This is because value investors believe that a stock's current market price is not reflective of its historical/future earnings and, therefore, chances of outperformance are higher.

But there is another side to the story that points to stocks with an increasing P/E. But this often-overlooked trend can prove pivotal in finding great stocks.

How Can Rising P/E Be Helpful?

Investors should note that stock prices move in tandem with earnings performance. If earnings come in stronger, the price of a stock soars. Solid quarterly earnings and guidance in turn boost the earnings forecast, leading to stronger demand for the stock and an uptrend in its price.

So, if the price is rising steadily, it means that investors are assured of the stock's fundamental strength, expect some strong positives out of it as well as solid and faster earnings growth. Moreover, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.

Here are five out of the 27 stocks:

Clovis Oncology: Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents. The stock has a Zacks Rank #2.

The average earnings surprise of CLVS for the past four quarters is 5.19%.

NiSource: This Zacks Rank #2 energy holding company, together with its subsidiaries, provides natural gas, electricity and other products and services in the United States.

The average earnings surprise of NI for the past four quarters is 0.33%.

DocuSign: Zacks Rank #2 DocuSign is a global provider of cloud-based software. The company's DocuSign Agreement Cloud is a cloud software suite that automates and connects the entire agreement process.

The average earnings surprise of DOCU for the past four quarters is 6.60%.

Root: This is the parent company of Root Insurance Company. It is a technology company revolutionizing personal insurance with a pricing model. ROOT currently carries a Zacks Rank #1.

The average earnings surprise of ROOT for the past four quarters is 22.44%.

Endava: The Zacks Rank #2 company provides information technology services. It offers software engineering, cloud transformation, test automation, technology consulting and other related services.

The average earnings surprise of DAVA for the past four quarters is 11.03%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit at:

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto


Phone: 312-265-9268


Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release.

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

NiSource, Inc (NI) - free report >>

DocuSign (DOCU) - free report >>

Endava PLC Sponsored ADR (DAVA) - free report >>

Root, Inc. (ROOT) - free report >>

Published in